Stay updated with breaking news from Adjuvanted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release
A vaccine manufactured in plants and developed in Canada Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3%
Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate Neutralizing antibody responses were 10 times higher than people recovering from COVID-19 No related severe adverse events reported Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) are pleased to report positive interim Phase 2 clinical trial safety and immunogenicity data for Medicago's plant-derived COVID-19 vaccine candidate, which has been tested in combination with GSK's pandemic adjuvant. These results are part of the ongoing Phase 2/3 study a...